Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma

American Journal of Surgical Pathology

Volumn 33, Issue 4, 2009, Pages 496-504

  Shin, Sandra J ^a   Simpson, Peter T ^b,c   Da Silva, Leonard ^b,c   Jayanthan, Janani ^b,c,d   Reid, Lynne ^b,c   Lakhani, Sunil R ^b,c,e   Rosen, Paul Peter ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d Wesley Research Institute   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Breast carcinoma; Comparative genomic hybridization; Microglandular adenosis

Indexed keywords

DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; CHEMISTRY; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; FIBROCYSTIC BREAST DISEASE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; INTRADUCTAL CARCINOMA; KARYOTYPING; MICRODISSECTION; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; KARYOTYPING; MICRODISSECTION; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 63849135922     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31818af361     Document Type: Article

References (26)

1. Bergamaschi A, Kim YH, Wang P, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006;45:1033-1040.
2. Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10:529-541.
3. Clement PB, Azzopardi JG. Microglandular adenosis of the breast-a lesion simulating tubular carcinoma. Histopathology. 1983; 7:169-180.
4. Diaz NM, McDivitt RW,Wick MR. Microglandular adenosis of the breast. An immunohistochemical comparison with tubular carcinoma. Arch Pathol Lab Med. 1991;115:578-582.
5. Eusebi V, Foschini MP, Betts CM, et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison. Am J Surg Pathol. 1993;17: 99-109.
6. Fridlyand J, Snijders AM, Ylstra B, et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 2006;6:96.
7. Hicks J, Krasnitz A, Lakshmi B, et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res. 2006;16:1465-1479.
8. James BA, Cranor ML, Rosen PP. Carcinoma of the breast arising in microglandular adenosis. Am J Clin Pathol. 1993;100:507-513.
9. Jones C, Ford E, Gillett C, et al. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res. 2004;10: 5988-5997.
10. Joshi MG, Lee AK, Pedersen CA, et al. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol. 1996;9:57-62.
11. Kay S. Microglandular adenosis of the female mammary gland: Study of a case with ultrastructural observations. Hum Pathol. 1985;16:637-641.
12. Khalifeh IM, Albarracin C, Diaz LK, et al. Clinical, Histopathologic, and Immunohistochemical Features of Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma. Am J Surg Pathol. 2008;32:544-552.
13. Kirchhoff M, Gerdes T, Rose H, et al. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry. 1998;31:163-173.
14. Koenig C, Dadmanesh F, Bratthauer GL, et al. Carcinoma arising in microglandular adenosis: An immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int J Surg Pathol. 2000;8: 303-315.
15. Lambros MB, Simpson PT, Jones C, et al. Unlocking pathology archives for molecular genetic studies: A reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest. 2006;86:398-408.
16. Loo LW, Grove DI, Williams EM, et al. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res. 2004;64:8541-8549.
17. McDivitt RW, Stewart FW, Berg GW. Tumors of the Breast. Atlas of Tumor Pathology, Second Series. Washington, DC: Armed Forces Institute of Pathology; 1968:91.
18. Nathanson KL, Shugart YY, Omaruddin R, et al. CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Hum Mol Genet. 2002;11:1327-1332.
19. Pierga JY, Reis-Filho JS, Cleator SJ, et al. Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy. Br J Cancer. 2007;96: 341-351.
20. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast: Role of comprehensive molecular pathology in characterization of an entity. J Pathol. 2005;207:1-13.
21. Rosen PP. Microglandular adenosis. A benign lesion simulating invasive mammary carcinoma. Am J Surg Pathol. 1983;7:137-144.
22. Rosenblum MK, Purrazzella R, Rosen PP. Is microglandular adenosis a precancerous disease? A study of carcinoma arising therein. Am J Surg Pathol. 1986;10:237-245.
23. Simpson PT, Gale T, Reis-Filho JS, et al. Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005;29: 734-746.
24. Tavassoli FA, Bratthauer GL. Immunohistochemical profile and differential diagnosis of microglandular adenosis. Mod Pathol. 1993;6: 318-322.
25. Tavassoli FA, Norris HJ. Microglandular adenosis of the breast. A clinicopathologic study of 11 cases with ultrastructural observations. Am J Surg Pathol. 1983;7:731-737.
26. Tirkkonen M, Johannsson O, Agnarsson BA, et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res. 1997;57: 1222-1227.